FDA urges adherence to specified intervals of mRNA COVID-19 vaccines

by on

FDA urges adherence to specified intervals of mRNA COVID-19 vaccines
tjordan_drupal
Jan 5, 2021

The Food and Drug Administration yesterday reminded the public of the importance of receiving COVID-19 vaccines in accordance to their agency authorizations, a process that FDA said will safely provide the “remarkable” levels of protection observed during large, randomized clinical trials.

Both approved vaccines, of the mRNA type, are approved for administration via two separate doses, given at either three- or four-week intervals.

“The available data continue to support the use of two specified doses of each authorized vaccine at specified intervals,” FDA said.

Headline

FDA urges adherence to specified intervals of mRNA COVID-19 vaccines
tjordan_drupal
Jan 5, 2021

The Food and Drug Administration yesterday reminded the public of the importance of receiving COVID-19 vaccines in accordance to their agency authorizations, a process that FDA said will safely provide the “remarkable” levels of protection observed during large, randomized clinical trials.

Both approved vaccines, of the mRNA type, are approved for administration via two separate doses, given at either three- or four-week intervals.

“The available data continue to support the use of two specified doses of each authorized vaccine at specified intervals,” FDA said.

Novel Coronavirus (SARS-CoV-2/COVID-19)
COVID-19: CDC, FDA and CMS Guidance
COVID-19: Vaccines and Therapeutics

Headline

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: